Latest Period
Q4 2025
Security Snapshot
NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) Institutional Ownership
CUSIP: 641288105
13F Institutional Holders and Ownership History from Q2 2021 to Q1 2026
Institutions Reporting
100
Shares (Excl. Options)
26,299,826
Price
$15.44
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- NPCE on Nasdaq
- Shares outstanding
- 33,235,472
- Price per share
- $13.15
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 26,299,826
- Total reported value
- $405,917,159
- % of total 13F portfolios
- 0%
- Share change
- +706,379
- Value change
- +$12,534,292
- Number of holders
- 100
- Price from insider filings
- $13.15
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- NPCE - NeuroPace Inc - Common Stock, par value $0.001 per share is tracked under CUSIP 641288105.
- 100 institutions reported positions in Q4 2025.
- 6 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 100 to 29 between Q4 2025 and Q1 2026.
- Reported value moved from $405,917,159 to $40,157,577.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 100 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 641288105?
CUSIP 641288105 identifies NPCE - NeuroPace Inc - Common Stock, par value $0.001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 641288105:
Significant Owners of NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Polar Capital Holdings Plc | 9.1% | $34,534,675 | 2,972,003 | Polar Capital Holdings Plc | 31 Mar 2025 | |||
| Soleus Private Equity Fund I, L.P. | 8.9% | $30,496,537 | 2,957,957 | Guy Levy | 30 Sep 2025 | |||
| ORBIMED ADVISORS LLC | 8% | -23% | $26,716,960 | -$8,095,783 | 2,614,184 | -23% | OrbiMed Advisors LLC | 30 Jun 2025 |
| MORGAN STANLEY | 8.3% | $28,926,723 | 2,489,391 | Morgan Stanley | 31 Dec 2024 | |||
| Soleus Capital Master Fund, L.P. | 7% | $23,545,122 | 2,303,828 | Soleus Capital Management, L.P. | 30 Jun 2025 | |||
| Kent Lake PR LLC | 4.9% | -2% | $17,227,289 | +$116,944 | 1,482,555 | +0.68% | Kent Lake PR LLC | 31 Dec 2024 |
As of 31 Dec 2025, 100 institutional investors reported holding 26,299,826 shares of NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE). This represents 79% of the company’s total 33,235,472 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) together control 72% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Polar Capital Holdings Plc | 8.7% | 2,878,523 | -7.1% | 0.2% | $44,444,395 |
| Soleus Capital Management, L.P. | 8.1% | 2,703,208 | -8.6% | 1.8% | $41,737,532 |
| MORGAN STANLEY | 7.7% | 2,547,784 | +0.06% | 0% | $39,337,784 |
| ORBIMED ADVISORS LLC | 7.2% | 2,406,335 | -8% | 0.79% | $37,153,812 |
| BlackRock, Inc. | 7.2% | 2,383,917 | -1.4% | 0% | $36,807,679 |
| Driehaus Capital Management LLC | 4.5% | 1,511,289 | +61% | 0.16% | $23,334,302 |
| VANGUARD GROUP INC | 4.5% | 1,482,228 | +3.2% | 0% | $22,885,600 |
| First Light Asset Management, LLC | 4.1% | 1,349,482 | -0.78% | 1.6% | $20,836,002 |
| DEUTSCHE BANK AG\ | 2.8% | 929,522 | +0.08% | 0% | $14,351,820 |
| ARMISTICE CAPITAL, LLC | 2.4% | 792,000 | -39% | 0.3% | $12,228,480 |
| KOTLER KEVIN | 1.9% | 631,468 | 0% | 7.2% | $9,749,866 |
| FMR LLC | 1.9% | 624,947 | +0.1% | 0% | $9,649,182 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.8% | 596,248 | +6.5% | 0% | $9,208,225 |
| STATE STREET CORP | 1.3% | 447,864 | +9.8% | 0% | $6,915,020 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 1.2% | 396,619 | +32% | 0.04% | $6,123,797 |
| Nantahala Capital Management, LLC | 0.89% | 295,089 | 0% | 0.27% | $4,556,174 |
| NORTHERN TRUST CORP | 0.7% | 231,774 | -2% | 0% | $3,578,591 |
| Walleye Capital LLC | 0.69% | 228,847 | +345% | 0.02% | $3,533,398 |
| RENAISSANCE TECHNOLOGIES LLC | 0.67% | 222,300 | +72% | 0.01% | $3,432,312 |
| Palumbo Wealth Management LLC | 0.64% | 214,175 | +8.5% | 0.82% | $3,306,862 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 0.64% | 213,892 | -1.3% | 0.5% | $3,302,492 |
| Qube Research & Technologies Ltd | 0.6% | 198,997 | -6.9% | 0% | $3,072,514 |
| TUDOR INVESTMENT CORP ET AL | 0.58% | 193,346 | +26% | 0.02% | $2,985,262 |
| ALGERT GLOBAL LLC | 0.52% | 172,926 | +77% | 0.04% | $2,670,000 |
| BANK OF AMERICA CORP /DE/ | 0.51% | 170,439 | +196% | 0% | $2,631,578 |
Institutional Holders of NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 3,054,632 | $40,157,577 | +$1,096,747 | $13.15 | 29 |
| 2025 Q4 | 26,299,826 | $405,917,159 | +$12,534,292 | $15.44 | 100 |
| 2025 Q3 | 25,945,404 | $267,500,978 | +$34,175,646 | $10.31 | 80 |
| 2025 Q2 | 22,505,448 | $250,711,399 | -$19,749,912 | $11.14 | 98 |
| 2025 Q1 | 23,932,784 | $294,127,661 | +$42,108,506 | $12.29 | 89 |
| 2024 Q4 | 20,868,828 | $233,522,000 | +$8,990,314 | $11.19 | 61 |
| 2024 Q3 | 14,795,861 | $103,125,040 | +$1,471,249 | $6.97 | 48 |
| 2024 Q2 | 14,430,601 | $109,095,635 | +$4,457,712 | $7.56 | 51 |
| 2024 Q1 | 13,364,973 | $176,414,273 | +$9,053,052 | $13.20 | 53 |
| 2023 Q4 | 12,690,314 | $130,836,764 | +$2,444,618 | $10.31 | 41 |
| 2023 Q3 | 18,073,997 | $175,859,892 | +$5,454,271 | $9.73 | 24 |
| 2023 Q2 | 17,503,080 | $78,589,150 | -$756,243 | $4.49 | 20 |
| 2023 Q1 | 17,670,188 | $81,990,736 | +$1,754,483 | $4.64 | 24 |
| 2022 Q4 | 17,357,024 | $25,862,002 | -$2,680,436 | $1.49 | 22 |
| 2022 Q3 | 18,161,017 | $68,102,000 | -$1,024,177 | $3.75 | 27 |
| 2022 Q2 | 18,426,044 | $91,207,000 | -$26,340 | $4.95 | 26 |
| 2022 Q1 | 18,210,639 | $149,512,180 | -$117,404 | $8.21 | 37 |
| 2021 Q4 | 18,012,051 | $181,543,000 | +$1,949,052 | $10.08 | 41 |
| 2021 Q3 | 11,190,051 | $177,393,000 | +$509,015 | $15.85 | 39 |
| 2021 Q2 | 10,905,701 | $259,451,000 | +$259,451,000 | $23.79 | 44 |